Clinical trials sponsored by Novo Nordisk A/S

Phase breakdown

Conditions studied

Recruiting trials led by Novo Nordisk A/S

• A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants
  NCT07532863 · Phase: Not specified · Ages: 40 Years to 70 Years · Sex: All (male and female) · 6 locations
• A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
  NCT06979375 · Phase: Phase 2 · Ages: 40 Years to 84 Years · Sex: All (male and female) · 92 locations
• A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
  NCT06979362 · Phase: Phase 2 · Ages: 40 Years to 84 Years · Sex: All (male and female) · 117 locations
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 147 locations
• A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
  NCT07415954 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 63 locations
• A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
  NCT07668388 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 70 locations
• A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
  NCT07481630 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 82 locations
• A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity
  NCT07578584 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
  NCT07557953 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
  NCT07710729 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: Female · 1 location
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · 106 locations
• A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes
  NCT07270731 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat
  NCT07214870 · Phase: Phase 1 · Ages: 18 Years to 69 Years · Sex: All (male and female) · 1 location
• A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
  NCT07710768 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
  NCT07253285 · Phase: Phase 3 · Ages: 8 Years to 18 Years · Sex: All (male and female) · 121 locations
• A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
  NCT07395687 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 3 locations
• A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
  NCT07218627 · Phase: Phase 1 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
  NCT07597018 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DM
  NCT07570992 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 303 locations
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
  NCT07567001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1676 locations
• A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Obesity, Compared to a Low-calorie Diet or Placebo
  NCT07757087 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
  NCT07112339 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 75 locations
• A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
  NCT07411560 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: Female · 1 location
• A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants
  NCT07656454 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 175 locations
• A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
  NCT07184086 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity
  NCT07693868 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
  NCT07437079 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
  NCT07503210 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 72 locations
• AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
  NCT07339423 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 72 locations
• AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
  NCT07533175 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 74 locations
• AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
  NCT07571109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 92 locations
• AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
  NCT07509307 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 81 locations
• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
  NCT07207811 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 295 locations
• Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
  NCT07607587 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
  NCT07225816 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
  NCT07770841 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 62 locations
• Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108
  NCT07153172 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
  NCT07527195 · Phase: Phase 1 · Ages: 50 Years to 70 Years · Sex: All (male and female) · 1 location
• Weight Loss in Adults Using Semaglutide (Real-world Study)
  NCT07627074 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials is Novo Nordisk A/S recruiting for?

Novo Nordisk A/S is the lead sponsor of 41 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.